Lv4
610 积分 2023-06-29 加入
Natural history and progression of metabolic dysfunction-associated steatotic liver disease
17小时前
已完结
Metabolic Dysfunction–Associated Steatotic Liver Disease in Adults
17小时前
已完结
Primary Biliary Cholangitis
7天前
已关闭
Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial
11天前
已完结
Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial
11天前
已完结
Health-related quality of life (HRQL) assessments in a 52-week, double-blind, randomized, placebo-controlled phase III study of resmetirom (MGL-3196) in patients with metabolic dysfunction–associated steatohepatitis (MASH) and fibrosis
1个月前
已完结
Real‐world pharmacovigilance assessment of drug‐induced male hypogonadism risks: An analysis of FDA adverse drug event data
1个月前
已完结
Guideline of guidelines: testosterone therapy for testosterone deficiency
1个月前
已完结
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
1个月前
已完结
Primary biliary cholangitis and the narrowing gap towards optimal disease control
2个月前
已完结
皖公网安备34019202002308
